STOK 8-K 2026-06-30

Stoke Therapeutics, Inc. (STOK) 8-K dated 2026-06-30 — accession 0001193125-26-289409. This URL is the filing, not the STOK hub.

Stoke Therapeutics, Inc. (STOK) is a biotechnology company listed on NASDAQ.

Stoke Therapeutics, Inc. filed a 8-K on 2026-06-30. Accession 0001193125-26-289409.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.

Not investment advice. The STOK SEC hub lists recent forms. The stock page is the research view.